Dr. Nazmul Kabir Qureshi, Consultant and Center Director of Uttara NHN, speaking at a Scientific Seminar on “Empagliflozin-The only oral anti-diabetic drug reduces CKD progression & CVD” arranged by NIPRO JMI Pharma Limited in the city recently. Md. Mizanur Rahman, CEO of the company and Dr. Muhammad Abu Salim, Consultant and Center Director of BIHS, Tongi were also spoken.

Dr. Nazmul Kabir Qureshi, Consultant and Center Director of Uttara NHN, speaking at a Scientific Seminar on "Empagliflozin-The only oral anti-diabetic drug reduces CKD progression & CVD" arranged by NIPRO JMI Pharma Limited in the city recently. Md. Miz
Dr. Nazmul Kabir Qureshi, Consultant and Center Director of Uttara NHN, speaking at a Scientific Seminar on "Empagliflozin-The only oral anti-diabetic drug reduces CKD progression & CVD" arranged by NIPRO JMI Pharma Limited in the city recently. Md. Miz
block
block